Top

Published in:

01-06-2013 | Original Article

Lower urinary tract symptoms in relation to region of birth in 95,393 men living in Australia: the 45 and Up Study

Authors: Isabel Latz, Marianne Weber, Rosemary Korda, David Smith, Mark Clements, Manish Patel, Terry Dwyer, Gabriella Tikellis, Emily Banks

Published in: World Journal of Urology | Issue 3/2013

Abstract

Purpose

Lower urinary tract symptoms (LUTS) are very common among older men globally, but evidence regarding the relationship between LUTS and country of origin is limited. This study aimed to investigate the relationship between the prevalence of LUTS and region of birth in a large, ethnically diverse population of older men resident in New South Wales, Australia.

Methods

Data on LUTS, demographic and behavioural factors were collected by postal questionnaire from 2006 to 2009 and analysed for 95,393 men aged 45 and over from the 45 and Up Study, who had not had previous prostate surgery. Logistic regression was used to investigate the association between region of birth and moderate/severe LUTS, ascertained using a modified International Prostate Symptom Score, adjusting for age, income, education, alcohol consumption and smoking.

Results

Overall, 18,530 (19.4 %) men had moderate or severe LUTS. Compared to Australian-born men, prevalence of moderate/severe LUTS was significantly higher in men born in the Middle East & North Africa, Southeast Asia and North America regions (adjusted odds ratios (OR) = 1.43; 95 % CI = 1.23–1.66, OR = 1.25; 1.10–1.42, OR = 1.26; 1.05–1.52, respectively), whereas men from the UK & Ireland had significantly lower prevalence (OR = 0.85; 0.80–0.90). Patterns of association were generally similar for storage- and voiding-related types of LUTS. However, participants born in Sub-Saharan Africa showed a significantly elevated prevalence of moderate/severe voiding symptoms (1.22; 1.03–1.45) but not storage symptoms, compared to Australian-born respondents.

Conclusion

The prevalence of LUTS and of specific subtypes of LUTS varies according to region of birth.

Available only for authorised users

Meigs JB, Mohr B, Barry MJ, Collins MM, McKinlay JB (2001) Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 54(9):935–944PubMedCrossRef

Holden C, McLachlan R, Pitts M, Cumming RG, Wittert G, Agius P, Handelsman D, de Kretser D (2005) Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men. Lancet 366:218–224PubMedCrossRef

Ward J, Sladden M (1994) Urinary symptoms in older men, their investigation and management: is there an epidemic of undetected morbidity in the waiting room? Fam Pract 11(3):251–259. doi:10.1093/fampra/11.3.251 PubMedCrossRef

Thorpe A, Neal D (2003) Benign prostatic hyperplasia. The Lancet 361(9366):1359–1367CrossRef

Kang D, Andriole GL, Van De Vooren RC, Crawford D, Chia D, Urban DA, Reding D, Huang WY, Hayes RB (2004) Risk behaviours and benign prostatic hyperplasia. BJU Int 93(9):1241–1245PubMedCrossRef

Roberts RO, Tsukamoto T, Kumamoto Y, Rhodes T, Masumori N, Miyake H, Girman CJ, Jacobsen SJ, Lieber MM (1997) Association between cigarette smoking and prostatism in a Japanese community. Prostate 30(3):154–159. doi:10.1002/(sici)1097-0045(19970215)30:3<154::aid-pros2>3.0.co;2-m PubMedCrossRef

Giovannucci E, Rimm EB, Chute CG, Kawachi I, Colditz GA, Stampfer MJ, Willett WC (1994) Obesity and benign prostatic hyperplasia. Am J Epidemiol 140(11):989–1002PubMed

Parsons JK, Kashefi C (2008) Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol 53(6):1228–1235PubMedCrossRef

Platz EA, Kawachi I, Rimm EB, Colditz GA, Stampfer MJ, Willett WC, Giovannucci E (1998) Physical activity and benign prostatic hyperplasia. Arch Intern Med 158(21):2349–2356. doi:10.1001/archinte.158.21.2349 PubMedCrossRef

10.

Suzuki S, Platz EA, Kawachi I, Willett WC, Giovannucci E (2002) Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia. Am J Clin Nutr 75(4):689–697PubMed

11.

Rohrmann S, Giovannucci E, Willett WC, Platz EA (2007) Fruit and vegetable consumption, intake of micronutrients, and benign prostatic hyperplasia in US men. Am J Clin Nutr 85(2):523–529PubMed

12.

Ambrosini GL, De Klerk NH, Mackerras D, Leavy J, Fritschi L (2008) Dietary patterns and surgically treated benign prostatic hyperplasia: a case control study in Western Australia. BJU Int 101(7):853–860. doi:10.1111/j.1464-410X.2007.07345.x PubMedCrossRef

13.

Fitzgerald MP, Link CL, Litman HJ, Travison TG, McKinlay JB (2007) Beyond the lower urinary tract: the association of urologic and sexual symptoms with common illnesses. Eur Urol 52(2):407–415PubMedCrossRef

14.

Kristal AR, Schenk JM, Song Y, Arnold KB, Neuhouser ML, Goodman PJ, Lin DW, Stanczyk FZ, Thompson IM (2008) Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol 168(12):1416–1424. doi:10.1093/aje/kwn272 PubMedCrossRef

15.

Neuhouser ML, Schenk J, Song YJ, Tangen CM, Goodman PJ, Pollak M, Penson DF, Thompson IM, Kristal AR (2008) Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial. Prostate 68(13):1477–1486. doi:10.1002/pros.20819 PubMedCrossRef

16.

Safarinejad MR (2008) Prevalence of benign prostatic hyperplasia in a population-based study in Iranian men 40 years old or older. Int Urol Nephrol 40(4):921–931PubMedCrossRef

17.

Fritschi L, Tabrizi J, Leavy J, Ambrosini G, Timperio A (2007) Risk factors for surgically treated benign prostatic hyperplasia in Western Australia. Public Health 121(10):781–789PubMedCrossRef

18.

Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Weiss N, Goodman P, Antvelink CM, Penson DF, Thompson IM (2007) Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urol 177(4):1395–1400 quiz 1591PubMedCrossRef

19.

Jin B, Turner L, Zhou Z, Zhou EL, Handelsman DJ (1999) Ethnicity and migration as determinants of human prostate size. J Clin Endocrinol Metab 84(10):3613–3619. doi:10.1210/jc.84.10.3613 PubMedCrossRef

20.

Morrison AS (1992) Risk factors for surgery for prostatic hypertrophy. Am J Epidemiol 135(9):974–980PubMed

21.

Platz EA, Kawachi I, Rimm EB, Willett WC, Giovannucci E (2000) Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study. J Urol 163(2):490–495PubMedCrossRef

22.

Sladden MJ, Hughes AM, Hirst GH, Ward JE (2000) A community study of lower urinary tract symptoms in older men in Sydney, Australia. Aust N Z J Surg 70(5):322–328PubMedCrossRef

23.

Gupta A, Gupta S, Pavuk M, Roehrborn CG (2006) Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans. Urology 68(6):1198–1205PubMedCrossRef

24.

Sidney S, Quesenberry CP Jr, Sadler MC, Guess HA, Lydick EG, Cattolica EV (1991) Incidence of surgically treated benign prostatic hypertrophy and of prostate cancer among blacks and whites in a prepaid health care plan. Am J Epidemiol 134(8):825–829PubMed

25.

Welch G, Kawachi I, Barry MJ, Giovannucci E, Colditz GA, Willett WC (1998) Distinction between symptoms of voiding and filling in benign prostatic hyperplasia: findings from the health professionals follow-up study. Urology 51(3):422–427PubMedCrossRef

26.

Banks E, Redman S, Jorm L, Armstrong B, Bauman A, Beard J, Beral V, Byles J, Corbett S, Cumming R (2008) Cohort profile: the 45 and Up Study. Int J Epidemiol 37(5):941–947. doi:10.1093/ije/dym184 PubMedCrossRef

27.

Barry MJ, Fowler FJ Jr, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT (1992) The American Urological Association symptom index for benign prostatic hyperplasia, the measurement committee of the American Urological Association. J Urol 148(5):1549–1557PubMed

28.

Harvard University, Institute for health metrics and evaluation at the University of Washington, Johns Hopkins University, University of Queensland, World Health Organization (2007) The global burden of diseases, injuries, and risk factors operations manual (draft)

29.

World Health Organization (1998) Obesity: preventing and managing the global epidemic. World Health Organization, Geneva

30.

Dirks J, Remuzzi G, Horton S, Schieppati A, Hasan Rizvi SA (2006) Diseases of the kidney and the urinary system. In: Jamison DT, Breman JG, Measham AR et al (eds) Disease control priorities in developing countries, 2nd edn. Oxford University Press, New York

31.

Hochreiter WW, Bushman W (1999) Urinary tract infection: a moving target. World J Urol 17(6):364–371. doi:10.1007/s003450050162 PubMedCrossRef

32.

Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AMY, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hyer MB (1993) Migration patterns and breast cancer risk in Asian–American women. J Natl Cancer Inst 85(22):1819–1827. doi:10.1093/jnci/85.22.1819 PubMedCrossRef

33.

Australian Bureau of Statistics (2006) Census of population and housing. Commonwealth of Australia

34.

Mealing NM, Banks E, Jorm LR, Steel DG, Clements MS, Rogers KD (2010) Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs. BMC Med Res Methodol 10:26. doi:10.1186/1471-2288-10-26 PubMedCrossRef

Title: Lower urinary tract symptoms in relation to region of birth in 95,393 men living in Australia: the 45 and Up Study
Authors: Isabel Latz
Marianne Weber
Rosemary Korda
David Smith
Mark Clements
Manish Patel
Terry Dwyer
Gabriella Tikellis
Emily Banks
Publication date: 01-06-2013
Publisher: Springer-Verlag
Published in: World Journal of Urology / Issue 3/2013
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-012-0937-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Lower urinary tract symptoms in relation to region of birth in 95,393 men living in Australia: the 45 and Up Study

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2013

Microbial colonization and ureteral stent-associated storage lower urinary tract symptoms: the forgotten piece of the puzzle?

Diffusion of robotics into clinical practice in the United States: process, patient safety, learning curves, and the public health

PDE5 inhibition against acute renal ischemia reperfusion injury in rats: does vardenafil offer protection?

The effect of abdominal and pelvic floor muscle activation patterns on urethral pressure

Athermal nerve sparing robot-assisted radical prostatectomy: initial experience with microporous polysaccharide hemospheres as a topical hemostatic agent

Methicillin-resistant Staphylococcus aureus (MRSA) in an Austrian urological department: 10 years experience covering 95.161 patients